Bill > LD2201

This bill establishes new regulations for health care transactions involving private equity companies, hedge funds, or management services organizations (MSOs) in Maine, aiming to increase transparency and oversight. It defines key terms like "health care entity" (which includes providers, facilities, and provider organizations, but excludes nursing facilities and dental-only providers), "material change transaction" (defined as acquiring majority interest or operational control), and "management services organization" (an entity owned by a private equity company or hedge fund that provides management services to a health care provider also owned by the same entity). The bill mandates that health care entities must provide at least 180 days' notice to the state Department of Health and Human Services (DHHS) before completing such transactions, detailing the transaction's terms, goals, and impact on services, and this information will be made public unless deemed confidential proprietary information. DHHS will conduct a preliminary review within 60 days, and if certain thresholds are met (e.g., asset transfer over $100 million, potential for reduced competition, or significant impact on cost, quality, or access), a comprehensive review will be triggered, involving public hearings and an analysis by the Office of Affordable Health Care on factors like service quality, consumer concerns, pricing, workforce impact, and market share. DHHS has the authority to approve, conditionally approve, or disapprove these transactions, considering their impact on costs, access, quality, and equity, and can impose conditions or penalties for non-compliance. Additionally, the bill requires health care entities to report ownership and control information to a designated organization by July 1, 2027, and after any material change transaction, with this information largely becoming public to enhance transparency, except for certain sensitive identification numbers. The effective date for this Act is January 1, 2027.